Earlier heat maps

Heat map presentations

The following heat maps are available:

The maps below are heat maps which were updated in July 2016

The maps below are heat maps which were updated in May 2016

 

The maps below are heat maps which were updated in January 2016

The maps below are heat maps which were updated in October 2015

The maps below are heat maps which were updated in May 2015

The maps below are heat maps which were updated in January 2015

The maps below are heat maps which were updated in October 2014

A heat map at Area Team level for Q2 2010-11 to Q3 2012-13 for spend on Denosumab for Prevention of osteoporotic fractures in women aged 50 or over , based upon Use of NICE appraised medicines in the NHS in England – 2012, experimental statistics.

Heat maps at area team level on the ratio of use to expected use of:

Heat maps at CCG level showing relative use of medical technologies for the period October 2012 – September 2013 based upon Hospital Episode Statistics and CCG Registered Populations for October 2013.  Revised data is now available for Hospital Episode Statistics and CCG Registered Populations for January to December 2013.

A spreadsheet containing the underlying data for this can be accessed below:

Heat maps at NHS Trust Level on spend for 64 medicines purchased between April and September 2013 based upon Innovation Scorecard Table 3.1 March 2014.  Revised data is now available for April to December 2013.

Heat maps for the high profile medicines in the innovation scorecard Table 5

Medicines in Table 5 are used across primary and secondary care settings, so heat maps from different settings need to be considered together. The following atlases have been produced.